Detalhe da pesquisa
1.
Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic.
Br J Haematol
; 204(3): 892-897, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38013238
2.
Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group.
Br J Haematol
; 2024 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38811025
3.
Diagnosis of Bone Marrow Necrosis following Severe Vaso-Occlusive Crisis in Patient with Compound Heterozygous Sickle Cell Disease.
Transfus Med Hemother
; 50(4): 360-364, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767282
4.
Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome.
Blood Adv
; 7(19): 5799-5811, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450374
5.
The evolution of hematopoietic cells under cancer therapy.
Nat Commun
; 12(1): 4803, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34376657
6.
Outcomes of CD19 Chimeric Antigen Receptor T Cell Therapy in Patients with Gastrointestinal Tract Involvement of Large B Cell Lymphoma.
Transplant Cell Ther
; 27(9): 768.e1-768.e6, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077811
7.
Allogeneic hematopoietic cell transplantation with sequential conditioning regimen in relapsed refractory acute myeloid leukemia.
Bone Marrow Transplant
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38778147
8.
Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF.
Leuk Res
; 135: 107403, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37837718